Norris Medicines Limited (NORRIS.BO)
INR 16.63
(-4.21%)
INR 16.63
(-4.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 56.35 Million INR | -32.57% |
| 2022 | 83.58 Million INR | -11.44% |
| 2021 | 94.38 Million INR | -22.96% |
| 2020 | 122.51 Million INR | 56.19% |
| 2019 | 78.43 Million INR | -51.78% |
| 2018 | 162.66 Million INR | 19.86% |
| 2017 | 135.71 Million INR | -33.66% |
| 2016 | 204.56 Million INR | 8.49% |
| 2015 | 188.56 Million INR | 0.96% |
| 2014 | 186.77 Million INR | -9.79% |
| 2013 | 207.04 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.24 Million INR | -51.27% |
| 2023 Q1 | 9.46 Million INR | -21.98% |
| 2023 FY | 56.35 Million INR | -32.57% |
| 2023 Q4 | 14.87 Million INR | 130.17% |
| 2023 Q3 | 6.46 Million INR | -74.71% |
| 2023 Q2 | 25.55 Million INR | 170.0% |
| 2022 Q3 | 31.64 Million INR | 4.5% |
| 2022 FY | 83.58 Million INR | -11.44% |
| 2022 Q1 | 9.53 Million INR | 13.65% |
| 2022 Q2 | 30.27 Million INR | 217.68% |
| 2022 Q4 | 12.13 Million INR | -61.66% |
| 2021 FY | 94.38 Million INR | -22.96% |
| 2021 Q4 | 8.38 Million INR | -44.37% |
| 2021 Q3 | 15.07 Million INR | -31.45% |
| 2021 Q2 | 21.99 Million INR | -55.06% |
| 2021 Q1 | 48.93 Million INR | 90.09% |
| 2020 Q4 | 25.74 Million INR | -44.88% |
| 2020 FY | 122.51 Million INR | 56.19% |
| 2020 Q3 | 46.69 Million INR | 47.55% |
| 2020 Q2 | 31.64 Million INR | 71.79% |
| 2020 Q1 | 18.42 Million INR | 35.89% |
| 2019 Q4 | 13.55 Million INR | -23.17% |
| 2019 FY | 78.43 Million INR | -51.78% |
| 2019 Q1 | 29.63 Million INR | -16.97% |
| 2019 Q2 | 17.6 Million INR | -40.58% |
| 2019 Q3 | 17.64 Million INR | 0.23% |
| 2018 Q1 | 47.65 Million INR | 50.92% |
| 2018 FY | 162.66 Million INR | 19.86% |
| 2018 Q4 | 35.68 Million INR | -13.26% |
| 2018 Q3 | 41.13 Million INR | 7.71% |
| 2018 Q2 | 38.19 Million INR | -19.85% |
| 2017 Q2 | 32.36 Million INR | -7.76% |
| 2017 FY | 135.71 Million INR | -33.66% |
| 2017 Q1 | 35.08 Million INR | -19.64% |
| 2017 Q4 | 31.57 Million INR | -14.09% |
| 2017 Q3 | 36.75 Million INR | 13.56% |
| 2016 Q3 | 52.65 Million INR | -20.72% |
| 2016 Q2 | 66.41 Million INR | 58.93% |
| 2016 Q1 | 41.78 Million INR | -18.97% |
| 2016 FY | 204.56 Million INR | 8.49% |
| 2016 Q4 | 43.65 Million INR | -17.09% |
| 2015 FY | 188.56 Million INR | 0.96% |
| 2015 Q3 | 44.78 Million INR | -19.84% |
| 2015 Q2 | 55.86 Million INR | 52.17% |
| 2015 Q1 | 36.71 Million INR | -75.98% |
| 2015 Q4 | 51.57 Million INR | 15.15% |
| 2014 Q1 | 37.54 Million INR | 0.0% |
| 2014 FY | 186.77 Million INR | -9.79% |
| 2014 Q2 | 52.32 Million INR | 39.37% |
| 2014 Q3 | 52.54 Million INR | 0.44% |
| 2014 Q4 | 152.87 Million INR | 190.93% |
| 2013 FY | 207.04 Million INR | 0.0% |
| 2013 Q3 | 48.51 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sunil Healthcare Limited | 901.91 Million INR | 93.752% |
| Colinz Laboratories Limited | 70.29 Million INR | 19.83% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 96.143% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 97.211% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 94.626% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 93.434% |
| Beryl Drugs Limited | 271.24 Million INR | 79.223% |
| Cian Healthcare Limited | 616.95 Million INR | 90.865% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -206.583% |
| Concord Drugs Limited | 449.24 Million INR | 87.455% |
| Deccan Health Care Limited | 597.28 Million INR | 90.565% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 84.464% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 96.681% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 88.253% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -437.261% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 96.03% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 98.165% |
| Makers Laboratories Limited | 1.03 Billion INR | 94.569% |
| Medi-Caps Limited | 265.63 Million INR | 78.784% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.9% |
| Mercury Laboratories Limited | 755.59 Million INR | 92.541% |
| Phaarmasia Limited | 305.93 Million INR | 81.579% |
| Parmax Pharma Limited | 154.24 Million INR | 63.463% |
| Parnax Lab Limited | 1.88 Billion INR | 97.014% |
| Patidar Buildcon Limited | 2.3 Million INR | -2341.774% |
| PRAVEG LIMITED | 915.96 Million INR | 93.847% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 89.503% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 99.584% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -4940.799% |
| Smruthi Organics Limited | 1.27 Billion INR | 95.585% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 79.354% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 98.784% |
| Syschem (India) Limited | 2.33 Billion INR | 97.587% |
| Trident Lifeline Limited | 446.28 Million INR | 87.372% |
| Transchem Limited | 4.09 Million INR | -1274.54% |
| Trinity League India Limited | 2.95 Million INR | -1810.377% |
| Tyche Industries Limited | 696.83 Million INR | 91.913% |
| Denis Chem Lab Limited | 1.67 Billion INR | 96.642% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | 45.22% |
| Zenith Healthcare Limited | 144.71 Million INR | 61.058% |
| Zenlabs Ethica Limited | 585.63 Million INR | 90.377% |
| Panchsheel Organics Limited | 1.05 Billion INR | 94.644% |
| Vivanza Biosciences Limited | 278.89 Million INR | 79.793% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | 62.893% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 95.506% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 85.919% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 84.776% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 87.367% |
| Roopa Industries Limited | 715.53 Million INR | 92.124% |
| PANJON LTD. | 125.52 Million INR | 55.102% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | 62.708% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 99.129% |
| Crestchem Limited | 212.56 Million INR | 73.487% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -915.06% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 91.624% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 98.381% |
| Trimurthi Limited | 42.23 Million INR | -33.425% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 92.443% |
| Veerhealth Care Limited | 142.13 Million INR | 60.35% |
| Lactose (India) Limited | 1.13 Billion INR | 95.052% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 85.784% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 96.767% |
| Gennex Laboratories Limited | 867.14 Million INR | 93.501% |
| Godavari Drugs Limited | 1.56 Billion INR | 96.404% |
| Zenotech Laboratories Limited | 368.08 Million INR | 84.69% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 95.524% |
| Bharat Parenterals Limited | 2.59 Billion INR | 97.828% |
| Coral Laboratories Limited | 836.6 Million INR | 93.264% |
| Evoq Remedies Limited | 63.09 Million INR | 10.673% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 94.493% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 96.374% |
| Auro Laboratories Limited | 526.99 Million INR | 89.306% |